Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance
<p><strong>Objectives:</strong> Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB m...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023
|